UC Irvine researchers to test former Ebola drug in coronavirus clinical trial

Remdesivir was developed by Gilead Sciences, which has shut down its emergency access program for the drug due overwhelming demand.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.